Alemtuzumab monoclonal antibody drug. Targets CD52. Used in treatment of leukemia and multiple sclerosis. Generic name and stylized antibody represent

---

Alemtuzumab monoclonal antibody drug. Targets CD52. Used in treatment of leukemia and multiple sclerosis. Generic name and stylized antibody representation.

---

Size: 6626px × 2508px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: alemtuzumab, antibody, biological, biosimilar, biotech, biotechnology, cd52, chronic, cll, disease, drug, graft, gvhd, host, humanized, immunoglobulin, immunology, infusion, injection, inn, leukemia, lymphocyte, lymphocytic, lymphoma, mab, monoclonal, ms, multiple, nomenclature, peptide, protein, sclerosis